CME Group Inc. · NASDAQ:CME

CME — Nymex Holdings — Merger or Acquisition (March 2008)

16 slides from CME's merger presentation, Mar 17, 2008

  1. Slide 1: Filed by CME Group Inc. pursuant to Rule 425

    Slide 1: Filed by CME Group Inc. pursuant to Rule 425

    Filed by CME Group Inc. pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended. Subject Company: NYMEX Holdings, Inc. Subject Company’s Commission File No.: 001-33149

  2. Slide 2: Investor Presentation

    Slide 2: Investor Presentation

    Investor Presentation March 17, 2008

  3. Slide 3: Discussion of Forward-Looking Statements

    Slide 3: Discussion of Forward-Looking Statements

    Discussion of Forward-Looking Statements Statements in this presentation that are not historical facts are forward-looking statements. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes

  4. Slide 4: Compelling Transaction

    Slide 4: Compelling Transaction

    Compelling Transaction • Provides access to a full spectrum of commodity products • Combines complementary product lines and shared technologies Strategically Attractive • Enhances over-the-counter (OTC) capabilities • Expands NYMEX product growth opportunities by leveraging CME Group’s global capab

  5. Slide 5: CME Group Is the Best Partner for NYMEX

    Slide 5: CME Group Is the Best Partner for NYMEX

    CME Group Is the Best Partner for NYMEX NYMEX on CME Globex WTI ADV Comparison ADV (contracts in thousands) (contracts in thousands) 999 489 1,000 500 6 consecutive record quarters 2.3X 400 750 ICE 300 500 213 200 250 100 79 0 0 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 06 06 06 07 07 07 07 08

  6. Slide 6: Transaction Summary

    Slide 6: Transaction Summary

    Transaction Summary Price Per Share: $100.30 per share (1) Aggregate Consideration: $9.5 billion Each NYMEX Holdings shareholder will receive the equivalent of: - 0.1323 CME Group shares for each NYMEX Holdings share, and - $36.00 per share in cash per NYMEX Holdings share Shareholders will be given

  7. Slide 7: Expected Strategic Benefits

    Slide 7: Expected Strategic Benefits

    Expected Strategic Benefits Global Growth Financially Customer Attractive Benefits Substantial Benefits Worldwide Increased Partnerships Diversification Cost Synergies and Enhanced OTC Growth Expertise Opportunities 6

  8. Slide 8: Positioned to Drive Global Growth

    Slide 8: Positioned to Drive Global Growth

    Positioned to Drive Global Growth • CME Group will utilize its global capabilities and platform to drive NYMEX growth • Experienced and deep management • Proven strategy to grow electronic markets • Global marketing and sales infrastructure, and brand • Global distribution and relationships • NYMEX’

  9. Slide 9: Positioned to Drive Global Growth

    Slide 9: Positioned to Drive Global Growth

    Positioned to Drive Global Growth 6-Year CAGR (2001 – 2007) Global Futures Volume Global Energy Futures: 19% CME Group CAGR: 27% 9% Individual Equities Annual Global Energy Futures 44% (contracts in millions) Volume Equity Indexes Interest Rates 450 425 24% 400 350 300 250 200 150 4% 100 83 FX/Index

  10. Slide 10: Expected Customer Benefits

    Slide 10: Expected Customer Benefits

    Expected Customer Benefits Capital Efficiencies Operational Efficiencies • Combination of financial • Combined clearing development safeguards of CME Clearing • Maintain electronic trading • Reduce $15 million NYMEX efficiencies member firm equity holding • Reduce back office connections and other p

  11. Slide 11: Increased Diversification

    Slide 11: Increased Diversification

    Increased Diversification $1.77 billion CME Group Standalone 2007 Transaction Revenue Mix $2.33 billion Foreign Pro Forma 2007 Exchange 8% Transaction Revenue Mix Eurodollar Commodities 26% & Other 11% Metals 3% Eurodollar Energy 19% 22% Equities 29% Notes, Bonds & Other 26% $.57 billion Commodities

  12. Slide 12: Cost Synergy Opportunities

    Slide 12: Cost Synergy Opportunities

    Cost Synergy Opportunities Cost synergies are primarily driven by consolidation across Corporate areas and IT and Clearing platforms Cost Synergies • NYMEX to adopt CME (Approximately $60m) Group clearing model • Consolidate NYMEX trading IT/Clearing/ Administrative Operations floors from 2 to 1 at

  13. Slide 13: Business Opportunities

    Slide 13: Business Opportunities

    Business Opportunities Growing CME Group Markets Growing NYMEX Markets OTC Growth Apply CME Group Capabilities • Advance OTC Clearing growth • Leverage marketing and through combined product suites product development to increase and combined clearing/ClearPort ® volumes and expand customer capabili

  14. Slide 14: Combined OTC Expertise

    Slide 14: Combined OTC Expertise

    Combined OTC Expertise • With the addition of NYMEX, CME Group will have an expanded OTC presence in: • Energy – NYMEX ClearPort ® • Interest Rates – Swapstream, with cleared swaps to launch shortly • FX – FXMarketSpace ™ • The acquisition creates increased ability to serve OTC customers in the agri

  15. Slide 15: Worldwide Partnerships

    Slide 15: Worldwide Partnerships

    Worldwide Partnerships CME Globex access from over 80 countries Six telecommunications hubs in Europe and Asia New hubs planned in Seoul, Sao Paolo and Shanghai 14

  16. Slide 16: Road Map to Completion

    Slide 16: Road Map to Completion

    Road Map to Completion • File Joint Proxy Statement/Prospectus with SEC • CME Group shareholder vote, NYMEX Holdings shareholder vote and NYMEX member vote • Repurchase of at least 75 percent of NYMEX memberships • Regulatory approvals • Hart-Scott-Rodino (HSR) • Regulatory notifications • Commodity

Source: SEC EDGAR · 425 filed Mar 17, 2008

More decks from CME Group Inc.

All 102 CME decks